gallic acid has been researched along with wedelolactone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, H; Fang, Y | 1 |
| Goli, D; S, M; T, P | 1 |
| Goli, D; Maya, S; Prakash, T | 1 |
3 other study(ies) available for gallic acid and wedelolactone
| Article | Year |
|---|---|
Anti-inflammatory gallic Acid and wedelolactone are G protein-coupled receptor-35 agonists.
Topics: Anti-Inflammatory Agents; Caffeic Acids; Cinnamates; Coumaric Acids; Coumarins; Cromolyn Sodium; Ellagic Acid; Gallic Acid; HeLa Cells; HT29 Cells; Humans; Receptors, G-Protein-Coupled | 2012 |
Effect of wedelolactone and gallic acid on quinolinic acid-induced neurotoxicity and impaired motor function: significance to sporadic amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Brain; Coumarins; Disease Models, Animal; Encephalitis; Gallic Acid; Learning; Male; Motor Activity; Neuroprotective Agents; Quinolinic Acid; Rats, Wistar | 2018 |
Evaluation of neuroprotective effects of wedelolactone and gallic acid on aluminium-induced neurodegeneration: Relevance to sporadic amyotrophic lateral sclerosis.
Topics: Aluminum; Amyotrophic Lateral Sclerosis; Animals; Body Weight; Brain-Derived Neurotrophic Factor; Caspase 3; Coumarins; Female; Gallic Acid; Gene Expression Regulation; Glutamic Acid; Interleukin-6; Male; Mice; Neuroprotective Agents; Rats; Rotarod Performance Test; Tumor Necrosis Factor-alpha | 2018 |